strain_accession,species_name,species_id,gene_name,card_accession,mechanism,AMR_gene_ref_strain,card_drug_class,definition,amr_seqid,contig,strand,position,coverage,identity,host,source,source_detail,country,date,MLST,subspecies_id,subspecies_name
GCA_002101905.1,shimoidei,29313,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCA_002101905.1_AMRSEG0001,LQPU01000029.1,positive,5734-6053,92.75,86.25,,,,,2017/4/20,555.0,,
GCA_002101905.1,shimoidei,29313,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCA_002101905.1_AMRSEG0002,LQPU01000062.1,negative,108854-112279,97.19,80.84,,,,,2017/4/20,555.0,,
GCF_001722445.1,shimoidei,29313,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001722445.1_AMRSEG0001,NZ_MIHE01000007.1,negative,108284-111709,97.19,80.84,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :blood,United States of America,2016/9/9,555.0,,
GCF_001722445.1,shimoidei,29313,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001722445.1_AMRSEG0002,NZ_MIHE01000037.1,positive,1588-1907,92.75,86.25,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :blood,United States of America,2016/9/9,555.0,,
GCF_001722445.1,shimoidei,29313,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001722445.1_AMRSEG0003,NZ_MIHE01000055.1,negative,2617-3303,100.0,87.77,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :blood,United States of America,2016/9/9,555.0,,
GCF_900417275.1,shimoidei,29313,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_900417275.1_AMRSEG0002,NZ_UEGW01000001.1,negative,3392098-3392417,92.75,86.25,,,,,2018/7/8,655.0,,
GCF_900417275.1,shimoidei,29313,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_900417275.1_AMRSEG0003,NZ_UEGW01000001.1,negative,4793767-4794453,100.0,87.77,,,,,2018/7/8,655.0,,